# Facelift Randomized Controlled Trials Compliance With CONSORT Checklist: A Systematic Review

## TL;DR

This study reviews the quality of randomized trials on facelift surgery and finds that reporting is often poor, suggesting ways to improve future research.

## Contribution

The study evaluates adherence to CONSORT guidelines in facelift RCTs and identifies key areas needing improvement.

## Key findings

- Mean CONSORT adherence in facelift RCTs was 56%, with poor reporting on trial registration and tailored interventions.
- Only 3 out of 10 RCTs were at low risk of bias, and evidence quality was mostly low-moderate.
- The study recommends pre-registration, standardized datasets, and better CONSORT compliance to improve evidence quality.

## Abstract

Randomised controlled trials (RCTs) in facelift surgery remain few and variably reported; transparent, reproducible methods are essential to interpret efficacy and safety.

To assess the methodological quality and reporting standards of facelift RCTs using the Consolidated Standards of Reporting Trials (CONSORT) and CONSORT-NPT guidelines, identifying patterns of adherence and areas for improvement.

We conducted a PRISMA-guided systematic review of RCTs evaluating facelift techniques or perioperative strategies. RCTs focusing on facelift techniques were included based on study design and relevance. Adherence to the CONSORT 2010 or CONSORT-NPT 2017 checklist was retrospectively assessed for each included study. Risk of bias was assessed using the Cochrane RoB 2.0 tool, and evidence quality was appraised via GRADE.

Ten RCTs (n = 457; mean sample 46) met inclusion. Mean CONSORT adherence was 56%, with high for intervention description and statistical analysis (both 100%) but poor for tailored interventions (10%), trial registration (20%), and trial protocol (30%). Adherence showed weak correlations with journal impact factor (R² = 0.0024) and author count (R² = 0.171). Only 3 trials were low risk of bias; GRADE certainty was largely low-moderate, limited by imprecision and suspected publication bias.

Facelift RCTs show variable, often suboptimal reporting, leaving the evidence base thin despite rising demand. Strengthening trial quality requires field-wide pre-registration and protocol publication, validated outcome measures, and consistent CONSORT enforcement; a standardized minimum dataset and registry-based reporting would further bolster evidence for facial rejuvenation surgery.